Observational studyInternational journal of hematology2026
Post-marketing surveillance of quizartinib for relapsed or refractory FLT3-ITD-positive acute myeloid leukemia in Japan.
Yasushi Miyazaki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.